Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease.

[1]  Akshay S. Desai,et al.  Strategies for multivessel revascularization in patients with diabetes. , 2012, The New England journal of medicine.

[2]  Kappetein Ap,et al.  Off-pump or on-pump coronary-artery bypass grafting. , 2012 .

[3]  M. Mack,et al.  Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries. , 2012, JACC. Cardiovascular interventions.

[4]  Sean M. O'Brien,et al.  Comparative effectiveness of revascularization strategies. , 2012, The New England journal of medicine.

[5]  Antonio Colombo,et al.  Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. , 2011, European heart journal.

[6]  F. Fattirolli,et al.  Late postoperative atrial fibrillation after cardiac surgery: a national survey within the cardiac rehabilitation setting , 2011, Journal of cardiovascular medicine.

[7]  Stuart J Head,et al.  A crucial factor in shared decision making: the team approach , 2011, The Lancet.

[8]  B. Gersh,et al.  Trends, predictors, and outcomes of cerebrovascular events related to percutaneous coronary intervention: a 16-year single-center experience. , 2011, JACC. Cardiovascular interventions.

[9]  P. Serruys,et al.  Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. , 2011, The New England journal of medicine.

[10]  T. Huber.  Temporal Onset, Risk Factors, and Outcomes Associated With Stroke After Coronary Artery Bypass Grafting , 2011 .

[11]  Oliver Kuss,et al.  Off-pump versus on-pump coronary artery bypass grafting: a systematic review and meta-analysis of propensity score analyses. , 2010, The Journal of thoracic and cardiovascular surgery.

[12]  D. Delurgio,et al.  New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft. , 2010, Journal of the American College of Cardiology.

[13]  Antonio Colombo,et al.  5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. , 2010, Journal of the American College of Cardiology.

[14]  G. Angelini,et al.  Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. , 2010, Journal of the American College of Cardiology.

[15]  Antonio Colombo,et al.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[16]  J. Rumsfeld,et al.  Incidence and predictors of stroke associated with percutaneous coronary intervention. , 2009, The American journal of cardiology.

[17]  Sean M. O'Brien,et al.  The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. , 2009, The Annals of thoracic surgery.

[18]  Salim Yusuf,et al.  Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[19]  S. Pocock,et al.  Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials , 2009, The Lancet.

[20]  J. Haerting,et al.  Off-pump versus on-pump coronary artery bypass grafting: A systematic review and meta-analysis of propensity score analyses , 2009 .

[21]  P. Serruys,et al.  Long-Term Safety and Efficacy of Percutaneous Coronary Intervention With Stenting and Coronary Artery Bypass Surgery for Multivessel Coronary Artery Disease: A Meta-Analysis With 5-Year Patient-Level Data From the ARTS, ERACI-II, MASS-II, and SoS Trials , 2008, Circulation.

[22]  E. Hannan,et al.  Drug-Eluting Stents vs Coronary-Artery Bypass Grafting in Multivessel Coronary Disease , 2008 .

[23]  J. Forrester,et al.  Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease. , 2007, International journal of cardiology.

[24]  Deepak L. Bhatt,et al.  Presence of carotid and peripheral arterial disease in patients with left main disease. , 2007, The American journal of cardiology.

[25]  A. Íñiguez,et al.  Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease. , 2007, The American journal of cardiology.

[26]  K. Kent,et al.  Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention With Drug-Eluting Stents for Patients With Multivessel Coronary Artery Disease , 2007, Circulation.

[27]  Bari Investigators.  The final 10-year follow-up results from the BARI randomized trial. , 2007 .

[28]  M. Pfeffer,et al.  Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial , 2006, The Lancet.

[29]  Patrick W Serruys,et al.  The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. , 2006, American heart journal.

[30]  OttavioAlfieri,et al.  Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis , 2006 .

[31]  A. Germing.  Comparison of Coronary Artery Bypass Surgery with Percutaneous Coronary Intervention with Drug-Eluting Stents for Unprotected Left Main Coronary Artery Disease , 2006 .

[32]  Patrick W Serruys,et al.  Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. , 2005, Journal of the American College of Cardiology.

[33]  K. Harjai,et al.  Characteristics of cerebrovascular accidents after percutaneous coronary interventions. , 2004, Journal of the American College of Cardiology.

[34]  A. Galloway,et al.  Off-Pump Coronary Artery Bypass Grafting Reduces Mortality and Stroke in Patients With Atheromatous Aortas: A Case Control Study , 2003, Circulation.

[35]  Volkmar Falk,et al.  Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. , 2003, The Annals of thoracic surgery.

[36]  N. Weissman,et al.  Stroke Complicating Percutaneous Coronary Interventions: Incidence, Predictors, and Prognostic Implications , 2002, Circulation.

[37]  G. Dangas,et al.  Stroke After Coronary Artery Bypass: Incidence, Predictors, and Clinical Outcome , 2001, Stroke.

[38]  S F Murphy,et al.  Risk factors for early or delayed stroke after cardiac surgery. , 1999, Circulation.

[39]  James T. Willerson,et al.  Appointment of New Associate Editor for Circulation , 1996 .

[40]  Robert L. Frye,et al.  Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.

[41]  C. Peniston,et al.  Risk Factors for Stroke Following Coronary Bypass Surgery , 1995, Journal of cardiac surgery.

[42]  R. Sapsford,et al.  Disease of the left main coronary artery: early surgical results and their association with carotid artery stenosis. , 1993, British heart journal.